Viewing Study NCT02538705


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-03-04 @ 7:52 PM
Study NCT ID: NCT02538705
Status: COMPLETED
Last Update Posted: 2017-04-05
First Post: 2015-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
Sponsor: Artgen Biotech
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ulcers Related to Diabetic Foot Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetic foot syndrome View
None Ulcers View